BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

Post-LOE

aspirin; butalbital; caffeine; codeine phosphate

Dr. Reddy's Laboratories

ANDAORALCAPSULE

Approved

Mar 1999

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (aspirin; butalbital; caffeine; codeine phosphate) by Dr. Reddy's Laboratories is butalbital, a barbiturate, is a gaba a receptor agonist and may inhibit excitatory ampa receptors. Approved for the symptom complex of tension (or muscle contraction) headache, other non-opioid analgesics, alternative treatments are inadequate. First approved in 1999.

Drug data last refreshed Yesterday

Mechanism of Action

Butalbital, a barbiturate, is a GABA A receptor agonist and may inhibit excitatory AMPA receptors. Aspirin is a nonsteroidal anti-inflammatory drug and a non-selective irreversible inhibitor of cyclooxygenases. Caffeine is a methylxanthine and CNS stimulant. The exact mechanism with respect to the…

Indications (3)

the symptom complex of tension (or muscle contraction) headache other non-opioid analgesics

Worked on BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.